Leo Cancer Care Raises Series C Funding to Expand into Asian Markets

Leo Cancer Care raises Series C Funding

Leo Cancer Care (Linkedin), a radiation therapy company, has secured an undisclosed amount in Series C funding. With backing from McLaren Health Care Corporation, Cone Health, Wisconsin Alumni Research Foundation, Macmillan Cancer Support, and Aviko Radiopharmaceuticals, Leo Cancer Care is poised to expand into Asian markets, particularly Singapore, Japan, and South Korea.

Industry: Mental Health Care

Employee Count: 201-500

CEO: Stephen Towe (CEO Linkedin)

What Leo Cancer Care needs to buy: Leo Cancer Care is seeking partnerships with medical institutions and healthcare providers specializing in radiation therapy and cancer treatment. Companies involved in proton therapy, carbon ion therapy, and innovative radiation therapy solutions are ideal partners for Leo Cancer Care as they expand into Asian markets. Additionally, distributors and healthcare providers in Singapore, Japan, and South Korea can support Leo Cancer Care's market entry and establishment of a strong commercial presence in these regions.